Senseonics Holdings, Inc. (SENS)

Market Cap	440.33M
Revenue (ttm)	22.47M
Net Income (ttm)	-78.62M
Shares Out	651.85M
EPS (ttm)	-0.12
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,995,349
Open	0.7007
Previous Close	0.7070
Day's Range	0.6705 - 0.7099
52-Week Range	0.2500 - 1.4000
Beta	1.18
Analysts	Strong Buy
Price Target	2.00 (+196.08%)
Earnings Date	Mar 3, 2025

About SENS

Senseonics Holdings, Inc., a commercial-stage medical technology company, focuses on development and manufacturing of continuous glucose monitoring (CGM) systems for people with diabetes in the United States and internationally. The company’s products include Eversense, Eversense XL, Eversense E3, and Eversense 365 which are implantable CGM systems to measure glucose levels in people with diabetes via an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management. ...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 1996
• Employees: 117
• Stock Exchange: NYSEAMERICAN
• Ticker Symbol: SENS
• Website: https://www.senseonics.com

Financial Performance

In 2024, Senseonics Holdings's revenue was $22.47 million, an increase of 0.37% compared to the previous year's $22.39 million. Losses were -$78.62 million, 30.2% more than in 2023.

Analyst Forecast

According to one analyst, the rating for SENS stock is "Strong Buy" and the 12-month stock price forecast is $2.0.

Price Target

$2.0

(196.08% upside)

Analyst Consensus: Strong Buy